Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lars Fruergaard Jorgensen
Pharma
Novo Nordisk's CEO pockets a cool 13% raise in 2023
With the previous year in the books and big developments already in the mix for 2024, Novo Nordisk’s CEO nabbed a 13% raise for his 2023 performance.
Fraiser Kansteiner
Feb 7, 2024 11:02am
JPM24: In obesity field, Novo is 'just getting going,' CEO says
Jan 10, 2024 11:45am
Novo Nordisk will launch Wegovy in more countries, CEO says
Aug 28, 2023 10:03pm
Novo Nordisk isn't letting semaglutide rest on its laurels
Aug 29, 2022 8:00am
Novo Nordisk's Wegovy woes were an unexpected boon for Saxenda
Aug 3, 2022 2:50pm
Novo wows with phase 3 semaglutide data in obesity
Feb 11, 2021 11:08am